MESO-02

• Research type

  Research Study

• Full title

  A phase I/II study of first line Vorinostat with pemetrexed-cisplatin, in patients with malignant pleural mesothelioma

• IRAS ID

  27210

• Sponsor organisation

  University College London

• Eudract number

  2009-013638-26

• Clinicaltrials.gov Identifier

  NCT01353482

• Research summary

  Research Summary not published at request of researcher

• REC name

  London - Chelsea Research Ethics Committee

• REC reference

  11/LO/1216

• Date of REC Opinion

  24 Aug 2011

• REC opinion

  Further Information Favourable Opinion